Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$42.05 - $47.77 $4,793 - $5,445
-114 Reduced 0.22%
52,696 $2.29 Million
Q1 2022

May 09, 2022

SELL
$40.23 - $47.74 $3,459 - $4,105
-86 Reduced 0.16%
52,810 $2.3 Million
Q4 2021

Feb 02, 2022

SELL
$38.88 - $45.31 $177,137 - $206,432
-4,556 Reduced 7.93%
52,896 $2.33 Million
Q3 2021

Oct 14, 2021

SELL
$38.79 - $43.16 $51,164 - $56,928
-1,319 Reduced 2.24%
57,452 $2.2 Million
Q2 2021

Jul 22, 2021

BUY
$36.52 - $41.46 $120,954 - $137,315
3,312 Added 5.97%
58,771 $2.34 Million
Q1 2021

Apr 14, 2021

SELL
$34.27 - $40.01 $7,916 - $9,242
-231 Reduced 0.41%
55,459 $1.98 Million
Q4 2020

Feb 04, 2021

BUY
$34.07 - $39.94 $482,533 - $565,670
14,163 Added 34.11%
55,690 $2.05 Million
Q3 2020

Oct 21, 2020

BUY
$38.11 - $42.99 $577,557 - $651,513
15,155 Added 57.47%
41,527 $1.56 Million
Q2 2020

Jul 31, 2020

SELL
$37.87 - $43.58 $45,178 - $51,990
-1,193 Reduced 4.33%
26,372 $1.08 Million
Q1 2020

Apr 10, 2020

BUY
$32.47 - $48.83 $10,877 - $16,358
335 Added 1.23%
27,565 $1.04 Million
Q4 2019

Feb 04, 2020

BUY
$42.0 - $48.25 $390,726 - $448,869
9,303 Added 51.89%
27,230 $1.28 Million
Q3 2019

Nov 05, 2019

BUY
$40.46 - $43.52 $201,288 - $216,512
4,975 Added 38.41%
17,927 $765,000
Q2 2019

Aug 07, 2019

SELL
$39.4 - $42.7 $31,401 - $34,031
-797 Reduced 5.8%
12,952 $518,000
Q3 2018

Nov 01, 2018

BUY
$39.75 - $42.69 $123,225 - $132,339
3,100 Added 29.11%
13,749 $552,000
Q2 2018

Jul 30, 2018

BUY
$39.61 - $42.76 $3,961 - $4,276
100 Added 0.95%
10,649 $429,000
Q1 2018

May 01, 2018

SELL
$36.18 - $40.15 $84,009 - $93,228
-2,322 Reduced 18.04%
10,549 $412,000
Q4 2017

Feb 01, 2018

BUY
$35.34 - $41.9 $15,090 - $17,891
427 Added 3.43%
12,871 $456,000
Q3 2017

Nov 01, 2017

BUY
$39.44 - $41.55 $490,791 - $517,048
12,444
12,444 $505,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Wealth Trust Axiom LLC Portfolio

Follow Wealth Trust Axiom LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Trust Axiom LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Trust Axiom LLC with notifications on news.